Citius Oncology, Inc. Key Metrics

6 years of history · ending 2025-09-30 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Per Share Metrics

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

EPS (Diluted)↓-219.1% -$1
$-0
Book Value Per Share↑+137.8% +$0
$1
Free Cash Flow Per Share↓-109.7% -$0
$-0
Cash Per Share
$0
OCF Per Share↓-109.7% -$0
$-0
Return on Equity↓-281.5pts
-54.4%
Return on Assets↓-27.8pts
-26.7%
Return on Invested Capital↑+24.2pts
-40.8%
Current Ratio↓-95.3% -$11
0.56
Quick Ratio↓-99.1% -$12
0.11
Working Capital↓-6452.6% -$22M
$-22M
Net Current Asset Value↓-7661.7% -$29M
$-29M
Invested Capital↑+12885.6% +$45M
$45M
OCF / Net Income↑+276.1% +$0
0.22
FCF / Net Income↑+276.1% +$0
0.22
Accruals Ratio (Sloan)↓-19.7pts
-19.1%
Net Debt
$-4M
Net Debt / EBITDA
0.17
Interest Coverage
-107.89
Cash Coverage
-25.19
Tangible Common Equity↑+12885.6% +$45M
$45M
TCE / Total Assets↑+43.9pts
44.4%
NOPAT↓-16931.3% -$18M
$-19M
Cash ROIC↑+16.5pts
-12.1%
Stock Price (FY-end)↓-80.0% -$8
$2
Market Cap↑+991.0% +$135M
$149M
P/E Ratio
29.84
P/B Ratio↓-91.6% -$36
3.32
P/TB Ratio↓-91.6% -$36
3.32
P/OCF Ratio
748.65
P/FCF Ratio
748.65
Enterprise Value↑+962.3% +$131M
$145M
EV / FCF
748.65
FCF Yield↓-3.3pts
-3.7%
Shareholder Yield
-5.6%
R&D Yield
4.3%
Graham Number
$5
Shares Variation (YoY)
7.7%
Beta (5Y)
-0.56
Cost of Equity
1.7%
52W High↓-48.0% -$5
$5
52W Low↓-94.3% -$10
$1
Trailing Return 1Y
42.0%
F-Score (Piotroski)↑+0.0% +$0
3.00

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates